The US House of Representatives passed a federal „right-to-try“ bill. The bill, backed by President Donald Trump, would give terminally ill patients the right to seek drug treatments that remain in clinical trials and have passed phase one of the Food and Drug Administration’s approval process, but they have not been fully approved by the FDA.
Papildomos nuorodos
